E
Sell
3/14/2023Downgrade
Renalytix Plc (RENXF) was downgraded to E+ from D- on 03/14/2023.
D
Sell
2/23/2023Upgraded
Renalytix Plc (RTNXF) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and volatility index.
E
Sell
2/8/2023Downgrade
Renalytix Plc (RTNXF) was downgraded to E+ from D- on 2/8/2023 due to a large decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.4 to 0.58, and the quick ratio declined from 3.59 to 2.42.
D
Sell
7/1/2022Downgrade
Renalytix Plc (RTNXF) was downgraded to D- from D on 7/1/2022 due to a decline in the total return index, solvency index and valuation index. The quick ratio declined from 5.33 to 2.22.
D
Sell
5/5/2022Upgraded
Renalytix Plc (RTNXF) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index.
D
Sell
4/20/2022Downgrade
Renalytix Plc (RTNXF) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 7.56 to 5.33.
D
Sell
11/23/2021Upgraded
Renalytix Plc (RTNXF) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index.
D
Sell
11/8/2021Downgrade
Renalytix Plc (RTNXF) was downgraded to D- from D on 11/8/2021 due to a decline in the growth index, total return index and solvency index. The quick ratio declined from 13.42 to 9.31, total revenue declined 23.75% from $619 to $472, and EBIT declined 20.84% from -$8.2M to -$9.91M.
D
Sell
9/20/2021Downgrade
Renalytix Plc (RTNXF) was downgraded to D from D+ on 9/20/2021 due to a substantial decline in the total return index and volatility index.
D
Sell
8/16/2021Upgraded
Renalytix Plc (RTNXF) was upgraded to D+ from D on 8/16/2021 due to a significant increase in the total return index, solvency index and growth index. Total revenue increased 54.75% from $400 to $619.
D
Sell
7/2/2020None
Renalytix Plc (RENXF) was downgraded to D from U on 07/02/2020.
